Creator and chair of the Hong Kong Hereditary Breast Cancer Family Registry. Women’s Surgical Chapter founder with the College of Surgeons of Hong Kong—and its first chair. First woman to attain a clinical associate professorship in surgery in Hong Kong. Chief of the breast surgery division at the Tung Wah…...
Making the Right Connections
The Asian Fund for Cancer Research was well-represented at the 24th Chinese Biopharmaceutical Association (CBA) Annual Conference, held 10 and 11 June 2019, in Guangzhou. The event, conducted in conjunction with the 12th China Bioindustry Convention, included some of the most highly respected biotechnology and pharmaceutical industry companies, institutions and…...
AFCR Statement on the Hong Kong Cancer Strategy
The Asian Fund for Cancer Research made this statement following the Friday, 26 July, announcement and dissemination of the Hong Kong Cancer Strategy: The Asian Fund for Cancer Research proudly supports and is committed to helping vigorously pursue the newly unveiled Hong Kong Cancer Strategy. We will fiercely fight to…...
Sarcoma Origin Identified
Cancer is anything but a straightforward disease; one tumor type can be entirely different from another not only in location, but causal agent and origin. There is differentiation even within the same type of cancer. Take sarcoma, which is in fact an umbrella term for nearly 100 cancers originating in the skeleton…...
What promising cancer research may go unfunded this year… unless you help?
I am writing today to ask for your 2019 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Right now, talented scientists are waiting for funding to pursue potentially life-saving research projects. Generous friends like you will help determine which investigations will…...
Global Coalition for Adaptive Research’s Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer
The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week. GBM AGILE is the world’s first global adaptive clinical trial platform…...
Support Cancer Research
Our tireless fight against cancer is nothing without you. You see, we rely almost exclusively on the individual generosity of people like you for the dollars to fund our innovative cancer research programs. AFCR does not accept government grants or rely on pharmaceutical corporate dollars to fund our cutting-edge science…...
AFCR Scientific Advisory Board Chairman’s Brain Cancer Efforts Recognized
W.K. Alfred Yung, M.D., a brain cancer researcher and chairman of the Asian Fund for Cancer Research’s scientific advisory board, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s (CMDA) Society for Neuro-Oncology (SNO). The presentation was…...
